Expert Review of Clinical Pharmacology

Expert Rev Clin Pharmacol

1751-2433

1751-2441

Therapeutic Area

Clinical Pharmacology, Pharmacoeconomics, Pharmacogenetics & Pharmacogenomics, Pharmacology, Statistics, Toxicology

Biomedical Researchers, Clinical Pharmacologists, Clinicians, Epidemiologists, Industrial Scientists, Pharmaco-Epidemiologists, Pharmacologists, Physicians, Physicians - Medicine, Researchers

Expert Review of Clinical Pharmacology [ISSN 1751-2433]; [e-ISSN 1751-2441] is a MEDLINE-indexed, international journal publishing rigorously peer-reviewed review articles and original papers on all aspects of clinical safety, tolerability, efficacy and therapeutic applications. Letters to the Editor should discuss articles previously published in the journal. The journal also covers toxicity issues, adverse reactions, pharmacoeconomics, and societal issues. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore, the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery. Please note that the journal does not publish preclinical or Phase I-II studies, unless there is a clear indication for translational medicine. Each article is structured to incorporate the author's own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. Expert Review of Clinical Pharmacology aims to address the needs of clinical and pharmaceutical researchers, drug development specialists, physicians, and other specialists and players who are actively meeting such challenges in modern biomedical practice. The Editors welcome novel research in the following key areas: ADME studies and PK/PD modelling; Novel clinical trial design and conduct; Toxicity and carcinogenesis; Adverse effects/reactions, drug–drug and drug–disease interactions; Pharmacogenetics, genomics and the incorporation of new biomarkers in drug development and clinical practice; Pharmacoepidemiology, risk management and pharmacovigilance; Pharmacotherapy in specific groups of people, such as children, women, the immunocompromised, and different ethnicities; Impact on quality of life and pharmacoeconomic issues; Regulation of drug development and marketing; Epidemiology and biostatistics, The journal welcomes: Reviews, Original research, Editorials, Drug profiles, Meta-analyses, Letters to the Editor.

No associations affiliated with this journal

Taylor & Francis, Inc. - UK

Impact Factor JCR Categories/Rank Circulation Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines